To determine the overexpression of NUCKS1 in tumors, genomic data was statistical analyzed and displayed in Fig. 1, revealing a significant upregulation of NUCKS1 levels in 12 selected tumors when compared to their cognate adjacent tumor tissues or normal tissues, with the exception of ovarian cancer. This evidence concerns the gene NUCKS1 and ovarian carcinoma.